Term Description

USDA NAHLN labs regulatory test. Influenza A whole-genome sequencing assay is a molecular diagnostic technique that uses next-generation sequencing (NGS) technologies to identify the full nucleotide sequence of all eight RNA segments of the Influenza A virus. This assay enables comprehensive genetic characterization, surveillance of viral evolution, detection of mutations, and lineage classification. The labs part of the NAHLN network report this assay as a GenBank number. These accession numbers are used for referencing, data sharing, and comparative analysis in global influenza surveillance and research.

Part Description

LP150045-5   Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977. PMID: 271968 Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost. PMID: 18576944 Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template. PMID: 20858600 Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Influenza virus A whole genome segment sequence:ID:Pt:XXX:Nom:Sequencing
Long Common Name
Influenza virus A whole genome segment sequence [Identifier] in Specimen by Sequencing
Short Name
FLUAV whole genome ID Spec Seq
Display Name
FLUAV whole genome ID Sequencing Nom (Specimen) [ID]
Consumer Name Alpha Get Info
Influenza virus A whole genome segment sequence, Specimen

Part Model Get Info

  • Component
    Influenza virus A whole genome segment sequence
    LP448612-4
    • Analyte
      Influenza virus A whole genome segment sequence
      LP448612-4
      • Component Numerator
        Influenza virus A whole genome segment sequence
        LP448612-4
        • Component Numerator Core
          Influenza virus A whole genome segment sequence
          LP448612-4
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    ID
    LP6818-1
  • Time
    Pt
    LP6960-1
  • System
    XXX
    LP7735-6
    • System Core
      XXX
      LP7735-6
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    Sequencing
    LP150045-5

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.82
Last Updated
Version 2.82 (ADD)
Order vs. Observation
Observation

Member of these Groups Get Info

LOINC GroupGroup Name
LG32757-3Influenza virus

Language Variants Get Info

TagLanguageTranslation
it-ITItalian (Italy)Sequenza dell'intero segmento genomico del virus dell'influenza A:ID:Pt:XXX:Nom:Sequenziamento
Synonyms: Identificatore Intero genoma del virus dell''influenza A Microbiologia Punto nel tempo (episodio) Virus dell''influenza Virus dell''influenza A

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=111478-4